124 related articles for article (PubMed ID: 24099307)
1. Promising biomarkers for systemic lupus erythematosus.
Jung JY; Bae CB; Suh CH
Expert Opin Med Diagn; 2013 Nov; 7(6):601-13. PubMed ID: 24099307
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for systemic lupus erythematosus.
Ahearn JM; Liu CC; Kao AH; Manzi S
Transl Res; 2012 Apr; 159(4):326-42. PubMed ID: 22424435
[TBL] [Abstract][Full Text] [Related]
3. Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
Suh CH; Kim HA
Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305
[TBL] [Abstract][Full Text] [Related]
4. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
5. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
7. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
[TBL] [Abstract][Full Text] [Related]
8. Refractory disease in systemic lupus erythematosus.
Campar A; Farinha F; Vasconcelos C
Autoimmun Rev; 2011 Sep; 10(11):685-92. PubMed ID: 21600313
[TBL] [Abstract][Full Text] [Related]
9. Customising an antibody leukocyte capture microarray for systemic lupus erythematosus: beyond biomarker discovery.
Ho JW; Lin MW; Braet F; Su YY; Adelstein S; dos Remedios CG
Proteomics Clin Appl; 2010 Feb; 4(2):179-89. PubMed ID: 21137042
[TBL] [Abstract][Full Text] [Related]
10. The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.
Adhya Z; Borozdenkova S; Karim MY
Nephrol Dial Transplant; 2011 Oct; 26(10):3273-80. PubMed ID: 21372259
[TBL] [Abstract][Full Text] [Related]
11. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
Luijten KM; Tekstra J; Bijlsma JW; Bijl M
Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603
[TBL] [Abstract][Full Text] [Related]
12. The search for lupus biomarkers.
Liu CC; Ahearn JM
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):507-23. PubMed ID: 19591781
[TBL] [Abstract][Full Text] [Related]
13. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for systemic lupus erythematosus: a review and perspective.
Liu CC; Manzi S; Ahearn JM
Curr Opin Rheumatol; 2005 Sep; 17(5):543-9. PubMed ID: 16093831
[TBL] [Abstract][Full Text] [Related]
15. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
Wais T; Fierz W; Stoll T; Villiger PM
J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for systemic lupus erythematosus - a focus on organ damage.
Ding H; Shen Y; Hong SM; Xiang C; Shen N
Expert Rev Clin Immunol; 2024; 20(1):39-58. PubMed ID: 37712757
[TBL] [Abstract][Full Text] [Related]
17. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
Griffiths B; Mosca M; Gordon C
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
19. Circulating microparticles in systemic Lupus Erythematosus.
Nielsen CT
Dan Med J; 2012 Nov; 59(11):B4548. PubMed ID: 23171755
[TBL] [Abstract][Full Text] [Related]
20. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
